Opko Health, Inc. - Common Stock (NQ:OPK)

1.750 -0.020 (-1.13%)

Delayed Quote Updated: 4:00 PM EST, Nov 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Opko Health, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

OPKO Health (OPK) Q3 2026 Earnings Call Transcript ↗

Today 10:13 EST

Sale of BioReference brings $722 million in cash as the company narrows its focus to biotech.

Via The Motley Fool

Topics Earnings

What OPKO Health (OPK) Said on Its Q3 Earnings Call ↗

Today 1:14 EST

OPKO Health (NASDAQ:OPK) reported 16% growth in third-quarter revenue from continuing operations and outlined plans to focus on drug development and pharmaceutical products following its proposed sale...

Via MarketBeat

Topics Earnings

There are notable gap-ups and gap-downs in today's session. ↗

October 15, 2026

Via Chartmill

OPKO Health (NASDAQ:OPK) Posts Breakout Earnings Beat, Shares Surge 16% After-Hours ↗

July 27, 2026

Via Chartmill

Topics Earnings

OPKO Health Inc (NASDAQ:OPK) Misses Q1 Revenue Estimates, Shares Slide After Hours ↗

April 28, 2026

Via Chartmill

OPKO Health Inc (NASDAQ:OPK) Posts Strong Q4 2025 Beat, But Cautious 2026 Guidance Tempers Outlook ↗

February 26, 2026

Via Chartmill

Earnings Scheduled For October 29, 2025 ↗

October 29, 2025

Via Benzinga

Earnings Scheduled For July 31, 2025 ↗

July 31, 2025

Via Benzinga

Get insights into the top gainers and losers of Thursday's pre-market session. ↗

October 15, 2026

Via Chartmill

OPKO Health Pivots to Therapeutics, Eyes Data-Rich 12 to 18 Months ↗

September 11, 2026

OPKO Health (NASDAQ:OPK) outlined a strategy to shift its business mix toward therapeutics while continuing to streamline its diagnostics operations, with management highlighting a pipeline of...

Via MarketBeat

Why Opko Health Stock Surged by 33% on Tuesday ↗

July 28, 2026

It posted a beat-and-raise second quarter.

Via The Motley Fool

These stocks are moving in today's session ↗

July 28, 2026

Via Chartmill

Earnings Scheduled For April 30, 2025 ↗

April 30, 2025

Via Benzinga

Analyst Expectations For OPKO Health's Future ↗

April 25, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

July 28, 2026

Gainers OPKO Health (NASDAQ:OPK) shares increased by 34.7% to $1.67 during Tuesday's regular session. The company's market cap stands at $936.3 million. As per the press release, Q2 earnings came out...

Via Benzinga

Top stock movements in today's session. ↗

July 28, 2026

Via Chartmill

Which stocks are gapping on Tuesday? ↗

July 28, 2026

Via Chartmill

OPKO Health Q2 Earnings Call Highlights ↗

July 27, 2026

OPKO Health (NASDAQ:OPK) reported a narrower second-quarter loss as gains tied to its diagnostics restructuring and a China commercialization agreement helped lift revenue, while the company continued...

Via MarketBeat

Topics Earnings

Top movers in Monday's after hours session ↗

July 27, 2026

Via Chartmill

OPKO Health (OPK) Q4 2025 Earnings Call Transcript ↗

February 26, 2026

OPKO Health (OPK) Q4 2025 Earnings Call Transcript

Via The Motley Fool

Topics Earnings

OPKO Health Inc (NASDAQ:OPK) Q3 2025 Earnings: Profit Beat Sparks Rally Despite Revenue Miss ↗

October 29, 2025

OPKO Health Q3 2025 earnings beat estimates with a surprise profit, driving a positive market reaction despite a revenue miss.

Via Chartmill

Topics Earnings

Market Brief: After Viking Therapeutics’ Results, Is Entera Bio the Oral Platform Play to Watch? (NASDAQ: ENTX)

August 22, 2025

Via AB Newswire

OPKO Health (OPK) Q2 2025 Earnings Call Transcript ↗

August 07, 2025

Via The Motley Fool

Topics Earnings

Opko Health (OPK) Q2 Revenue Falls 14% ↗

August 01, 2025

Via The Motley Fool

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

July 31, 2025

Via Benzinga

OPKO Health Inc (NASDAQ:OPK) Q2 2025 Earnings Miss Estimates, Stock Plunges 7.8% ↗

July 31, 2025

OPKO Health's Q2 2025 earnings missed revenue and EPS estimates, causing a 7.8% stock drop. Weak performance in pharma/diagnostics segments and higher losses raised investor concerns.

Via Chartmill

Topics Earnings

This Rocket Lab Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Friday ↗

April 25, 2025

Via Benzinga

This Nano-Cap E-Commerce Play Saw 3,100% Jump In Retail Chatter Last Week: What's Behind The Surge? ↗

April 14, 2025

Late Friday, the company said the U.S.-China tariffs will have a material impact on anticipated sales of U.S. products into China.

Via Stocktwits

Topics Artificial Intelligence World Trade

OPKO Health Stock: A Deep Dive Into Analyst Perspectives (7 Ratings) ↗

April 07, 2025

Via Benzinga

Forecasting The Future: 6 Analyst Projections For OPKO Health ↗

March 19, 2025

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.